There are studies demonstrated that EMT phenotype is highest in the CD44+/CD24−/low breast cancer CSCs (7), and CSCs enriched from breast tumors and metastatic breast pleural effusions express markers similar to cells that have undergone an EMT [7], [14]. This evidence concerns the gene CD44 and breast carcinoma.